GoodRx Holdings (GDRX) Invested Capital (2019 - 2026)

GoodRx Holdings has disclosed Invested Capital across 8 years of filings, most recently posting $1.1 billion for Q2 2026.

• In Q2 2026, Invested Capital changed 0.1% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $1.1 billion (changed 0.1% YoY), while the FY2025 annual figure was $1.1 billion, down 9.19% from the prior year.
• Invested Capital came in at $1.1 billion for Q2 2026 at GoodRx Holdings, up from $1.1 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.6 billion in Q2 2023 to a low of $1.1 billion in Q3 2025.
• Average Invested Capital over 5 years is $1.3 billion, with a median of $1.3 billion recorded in 2024.
• Year-over-year, Invested Capital gained 6.13% in 2023 and retreated 22.72% in 2024.
• Over 5 years, Invested Capital stood at $1.5 billion in 2022, then slipped by 3.75% to $1.4 billion in 2023, then decreased by 14.25% to $1.2 billion in 2024, then decreased by 9.19% to $1.1 billion in 2025, then increased by 2.69% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $1.1 billion in Q2 2026, $1.1 billion in Q1 2026, and $1.1 billion in Q4 2025.